Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age60+
SponsorOnward Health, Inc
About this trial
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is:
Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?
Eligibility criteria
Qualifiers
All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;
have scheduled medical appointments at partner practices of Onward;
ages 60+
community-dwelling;
Disqualifiers
current enrollment in another transportation study;
already using any type of free or heavily subsized transportation service;
enrollees with comfort care only;
Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer
Trial design
Treatments tested in this trial
- Door-through-door companion rideshare
- Curb-to-curb rideshare services
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Onward Health, Inc
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov